Sonnet Biotherapeutics logo

Sonnet Biotherapeutics Share Price Today

(NASDAQ: SONN)

Sonnet Biotherapeutics share price is $1.4 & ₹119.27 as on 30 Apr 2025, 2.30 'hrs' IST

$1.4

-0.09

(-5.77%)

Market is closed - opens 7 PM, 30 Apr 2025

View live Sonnet Biotherapeutics share price in Dollar and Rupees. Guide to invest in Sonnet Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sonnet Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Sonnet Biotherapeutics share price movements

  • Today's Low: $1.40
    Today's High: $1.48

    Day's Volatility :5.57%

  • 52 Weeks Low: $1.10
    52 Weeks High: $16.00

    52 Weeks Volatility :93.13%

Sonnet Biotherapeutics (SONN) Returns

PeriodSonnet Biotherapeutics Holdings IncIndex (Russel 2000)
3 Months
-13.02%
0.0%
6 Months
-67.83%
0.0%
1 Year
-89.62%
0.0%
3 Years
-99.79%
-5.1%

Sonnet Biotherapeutics (SONN) Key Statistics

in dollars & INR

Previous Close
$1.49
Open
$1.5
Today's High
$1.4826
Today's Low
$1.4
Market Capitalization
$4.2M
Today's Volume
$107.0K
52 Week High
$16.0
52 Week Low
$1.1
Revenue TTM
$1000.0K
EBITDA
$-13.4M
Earnings Per Share (EPS)
$-10.45
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-285.35%

How to invest in Sonnet Biotherapeutics Stock (SONN) from India?

It is very easy for Indian residents to invest directly in Sonnet Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sonnet Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sonnet Biotherapeutics or SONN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sonnet Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sonnet Biotherapeutics shares which would translate to 0.609 fractional shares of Sonnet Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sonnet Biotherapeutics, in just a few clicks!

Returns in Sonnet Biotherapeutics (SONN) for Indian investors in Rupees

The Sonnet Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sonnet Biotherapeutics investment value today

Current value as on today

₹11,921

Returns

₹88,079

(-88.08%)

Returns from Sonnet Biotherapeutics Stock

₹90,169 (-90.17%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Sonnet Biotherapeutics (SONN)

-76%

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Sonnet Biotherapeutics Stock from India on INDmoney has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sonnet Biotherapeutics

  • Virtu Financial LLC

    1.32%

  • Citadel Advisors Llc

    0.80%

  • Two Sigma Investments LLC

    0.64%

  • Tower Research Capital LLC

    0.20%

Analyst Recommendation on Sonnet Biotherapeutics

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Sonnet Biotherapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Sonnet Biotherapeutics Stock (SONN)

What analysts predicted

Upside of 1328.57%

Target:

$20.00

Current:

$1.40

Insights on Sonnet Biotherapeutics Stock (Ticker Symbol: SONN)

  • Price Movement

    In the last 7 days, SONN stock has moved up by 14.4%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 18.62K → 1.0M (in $), with an average increase of 85.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -3.12M → -3.16M (in $), with an average decrease of 1.0% per quarter
  • SONN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 162.7%
  • SONN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.0% return, outperforming this stock by 190.8%
  • Price to Sales

    ForSONN every $1 of sales, investors are willing to pay $1.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Sonnet Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Sonnet Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sonnet Biotherapeutics (SONN) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Sonnet Biotherapeutics Holdings Inc logo
9.7%
-67.83%
-89.62%
-99.79%
-99.99%
Regeneron Pharmaceuticals, Inc. logo
-3.5%
-33.68%
-31.29%
-6.14%
16.46%
Beone Medicines Ltd logo
-8.24%
21.23%
62.23%
49.96%
78.11%
Vertex Pharmaceuticals Incorporated logo
2.53%
4.63%
26.54%
89.75%
95.01%
Alnylam Pharmaceuticals, Inc. logo
-5.61%
-9.46%
77.05%
83.29%
97.62%

About Sonnet Biotherapeutics

Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 to treat chemotherapy-induced peripheral neuropathy (CIPN), and diabetic peripheral neuropathy; SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer; SON-1411, a bifunctional combination of human interleukin 18 (IL-18) inhibitor binding protein and single-chain human IL-12 (IL-12) for solid tumor cancers; and SON-1400, a monofunctional fusion protein comprising the IL-18 binding protein resistant domain linked to the FHAB. It has a license agreement with New Life Therapeutics Pte, Ltd. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.
Organization
Sonnet Biotherapeutics
Employees
13
CEO
Mr. Raghu Rao
Industry
Consumer Services

Management People of Sonnet Biotherapeutics

NameTitle
Mr. Raghu Rao
Interim CEO & Director
Dr. John K. Cini Ph.D.
Chief Scientific Officer & Co-Founder
Mr. Donald J. Griffith CPA, CPA
CFO, Financial Controller & Director
Dr. Stephen J. McAndrew Ph.D.
President & Chief Business Officer
Dr. Gael Hedou Ph.D.
Chief Operating Officer
Ms. Susan Dexter
Chief Technical Officer
Dr. Richard T. Kenney FACP, M.D.
Chief Medical Officer
Mr. Manuel Dafonseca
Head of Clinical Operations

Important FAQs about investing in SONN Stock from India :

What is Sonnet Biotherapeutics share price today?

Sonnet Biotherapeutics share price today stands at $1.40, Open: $1.50 ; Previous Close: $1.49 ; High: $1.48 ; Low: $1.40 ; 52 Week High: $16.00 ; 52 Week Low: $1.10.

The stock opens at $1.50, after a previous close of $1.49. The stock reached a daily high of $1.48 and a low of $1.40, with a 52-week high of $16.00 and a 52-week low of $1.10.

Can Indians buy Sonnet Biotherapeutics shares?

Yes, Indians can invest in the Sonnet Biotherapeutics (SONN) from India.

With INDmoney, you can buy Sonnet Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sonnet Biotherapeutics at zero transaction cost.

How can I buy Sonnet Biotherapeutics shares from India?

It is very easy to buy Sonnet Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sonnet Biotherapeutics (SONN) be purchased?

Yes, you can buy fractional shares of Sonnet Biotherapeutics with INDmoney app.

What are the documents required to start investing in Sonnet Biotherapeutics stocks?

To start investing in Sonnet Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sonnet Biotherapeutics Stock (SONN)?

Today’s highest price of Sonnet Biotherapeutics (SONN) is $1.48.

Today’s lowest price of Sonnet Biotherapeutics (SONN) is $1.40.

What is today's market capitalisation of Sonnet Biotherapeutics?

Today's market capitalisation of Sonnet Biotherapeutics SONN is 4.2M

What is the 52 Week High and Low Range of Sonnet Biotherapeutics Stock (SONN)?

  • 52 Week High

    $16.00

  • 52 Week Low

    $1.10

What are the historical returns of Sonnet Biotherapeutics (SONN)?

  • 1 Month Returns

    9.7%

  • 3 Months Returns

    -67.83%

  • 1 Year Returns

    -89.62%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Sonnet Biotherapeutics ?

Mr. Raghu Rao is the current Chief Executive Officer (CEO) of Sonnet Biotherapeutics.